Real-world data of zanubrutinib treatment for patients with previously treated Waldenstrom Macroglobulinemia

被引：0

作者：

Jang, Seo Yoon ^{[1
]}

Kwon, Soyean ^{[1
]}

Byun, Ja Min ^{[1
]}

Koh, Youngil ^{[1
]}

Hong, Junshik ^{[1
]}

Yoon, Sung-Soo ^{[1
]}

机构：

[1] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-429

引用

页码：S277 / S277

页数：1

共 50 条

[1] Comparison of Zanubrutinib and Ibrutinib As Treatments for Waldenstrom Macroglobulinemia: A Real-World Retrospective Study
Iadevaia, Francesco
Hafer, Ramsay
Rohan, Thomas Z.
Khoo, Alan
Laurenti, Luca
Porcu, Pierluigi
BLOOD, 2024, 144 : 5111 - 5112
[2] Zanubrutinib for the treatment of Waldenstrom Macroglobulinemia
Lim, Kenneth J. C.
Tam, Constantine S.
EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (12) : 1303 - 1310
[3] Real-World Treatment Patterns and Healthcare Resource Utilization in Patients with Waldenstrom Macroglobulinemia Initiating First-Line Treatment with Ibrutinib or Zanubrutinib
Paludo, Jonas
Sarosiek, Shayna R.
von Keudell, Gottfried R.
Salkar, Monika
Zhou, Summera
Kim, Sonia
Cheng, Ning
Pacia, Michelle
Karve, Sudeep
Castillo, Jorge J.
BLOOD, 2023, 142
[4] Real-world data on the survival outcome of patients with newly diagnosed Waldenstrom macroglobulinemia
Cho, Jang Ho
Shim, Joon-Ho
Yoon, Sang Eun
Kim, Hee-Jin
Kim, Sun-Hee
Ko, Young Hyeh
Lee, Seung-Tae
Kim, Kihyun
Kim, Won Seog
Kim, Seok Jin
KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (03): : 668 - +
[5] Zanubrutinib for the treatment of adults with Waldenstrom macroglobulinemia
Sarosiek, Shayna
Sermer, David
Branagan, Andrew R.
Treon, Steven P.
Castillo, Jorge J.
EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (05) : 471 - 478
[6] Venetoclax in Previously Treated Waldenstrom Macroglobulinemia
Castillo, Jorge J.
Allan, John N.
Siddiqi, Tanya
Advani, Ranjana H.
Meid, Kirsten
Leventoff, Carly
White, Timothy P.
Flynn, Catherine A.
Sarosiek, Shayna
Branagan, Andrew R.
Demos, Maria G.
Guerrera, Maria L.
Kofides, Amanda
Liu, Xia
Munshi, Manit
Tsakmaklis, Nicholas
Xu, Lian
Yang, Guang
Patterson, Christopher J.
Hunter, Zachary R.
Davids, Matthew S.
Furman, Richard R.
Treon, Steven P.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (01) : 63 - +
[7] "Real-Life" Data of Zanubrutinib in Patients with Waldenstrom Macroglobulinemia - a Multi-Center Retrospective Study
Itchaki, Gilad
Benjamini, Ohad
Levi, Mor
Nemets, Anatoly
Yeganeh, Shay
Assaly, Mahdi
Gourevitch, Anna
Saban, Revital
Gatt, Moshe E.
Raanani, Pia
Vaxman, Iuliana
BLOOD, 2022, 140 : 11981 - 11982
[8] CHLORODEOXYADENOSINE THERAPY OF PATIENTS WITH WALDENSTROM MACROGLOBULINEMIA PREVIOUSLY TREATED WITH FLUDARABINE
DIMOPOULOS, MA
WEBER, DM
KANTARJIAN, H
KEATING, M
ALEXANIAN, R
ANNALS OF ONCOLOGY, 1994, 5 (03) : 288 - 289
[9] Ibrutinib As a Promising Treatment for Heavily Pretreated Waldenstrom Macroglobulinemia: A Real World Data
Ilhan, Osman
Seval, Guldane Cengiz
Avcu, Ferit
Ferhanoglu, Burhan
Cetin, Guven
Kurtoglu, Erdal
Atalay, Figen
Gulturk, Emine
Nalcaci, Meliha
Beksac, Meral
BLOOD, 2020, 136
[10] Ibrutinib in Previously Treated Waldenstrom's Macroglobulinemia
Treon, Steven P.
Tripsas, Christina K.
Meid, Kirsten
Warren, Diane
Varma, Gaurav
Green, Rebecca
Argyropoulos, Kimon V.
Yang, Guang
Cao, Yang
Xu, Lian
Patterson, Christopher J.
Rodig, Scott
Zehnder, James L.
Aster, Jon C.
Harris, Nancy Lee
Kanan, Sandra
Ghobrial, Irene
Castillo, Jorge J.
Laubach, Jacob P.
Hunter, Zachary R.
Salman, Zeena
Li, Jianling
Cheng, Mei
Clow, Fong
Graef, Thorsten
Palomba, M. Lia
Advani, Ranjana H.
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (15): : 1430 - 1440

← 1 2 3 4 5 →